MoneyWorks4Me

Venmax Drugs and Pharmaceuticals informs about disclosure

05 May 2025 Evaluate
Pursuant to SEBI Circular dated August 10, 2021, with regard to fund raising by issuance of debt securities by large entities, Venmax Drugs and Pharmaceuticals has informed that the Company does not fulfil the criteria specified in the above-mentioned SEBI Circular and hence as on 31st March 2025 the company does not fall in the category of ‘Large Corporate’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..